Skip to main content
. 2018 Aug 1;103(10):3925–3930. doi: 10.1210/jc.2018-01347

Figure 1.

Figure 1.

(a) Volumetric measurements of the intracranial tumor and liver metastasis across the patient’s clinical timeline and corresponding measurements of ACTH show response to treatment with immunotherapy. (b) MRI scans of the intracranial and liver sites before and after combination treatment with ipilimumab and nivolumab, mirroring response in (a). CAPTEM, capecitabine/TMZ; Carbo/Etop, carboplatin/etoposide; Ipi/Nivo, ipilimumab/nivolumab.